Implantica's Upcoming Q3 2025 Presentation Details

Author: Evelyn Baker Updated: 10-27-2025 04:54 AM

Implantica to Present Third Quarter 2025 Results

Implantica AG (publ) is set to unveil its third quarter 2025 results during a presentation scheduled for 15:00 CET on October 31. Investors and stakeholders will have the opportunity to engage in this insightful presentation that underscores the drive and progress made in the company's ongoing projects.

Webcast Participation for Investors

The presentation will be available in English through an interactive webcast, providing a seamless way for interested parties to join. Participants who wish to attend the webcast can do so easily by visiting the company's dedicated event page.

Teleconference Registration Details

There is also an option to join the discussion via teleconference. Individuals interested in this format are encouraged to register prior to the event. Registration will grant access to the necessary contact numbers and a conference ID, ensuring a hassle-free experience for all involved.

Meet the Speakers

This important event will feature key speakers from Implantica's leadership team, including:

Peter Forsell, CEO
Andreas Öhrnberg, CFO
Nicole Pehrsson, Chief Corporate Affairs Officer

Contact Information for Inquiries

For those seeking additional information or clarity regarding the event, Nicole Pehrsson at Investor Relations has offered her support. Interested parties can reach out via telephone at +41 43 505 20 57.

About Implantica AG

Implantica is revolutionizing the medtech sector with its dedication to innovative solutions that integrate seamlessly into the human body. The company’s flagship product, RefluxStop™, represents a significant advancement in addressing gastroesophageal reflux, showcasing strong potential to alter anti-reflux treatment protocols. Aiming to enhance eHealth capabilities, Implantica is expanding its product line with technologies that monitor various health parameters and enable remote communication with healthcare providers.

Implantica is publicly traded on the Nasdaq First North Premier Growth Market, ensuring transparency and accessibility for its investors.

Frequently Asked Questions

When will Implantica present its Q3 2025 results?

Implantica will present its Q3 2025 results on October 31 at 15:00 CET.

How can I participate in the presentation?

Participants can join the presentation via a webcast or teleconference. Registration details will be provided ahead of the event.

Who will be speaking at the presentation?

The event will feature key executives including CEO Peter Forsell, CFO Andreas Öhrnberg, and Chief Corporate Affairs Officer Nicole Pehrsson.

What products does Implantica focus on?

Implantica's flagship product is RefluxStop™, aimed at preventing gastroesophageal reflux, along with innovative eHealth solutions.

Where is Implantica listed?

Implantica is listed on the Nasdaq First North Premier Growth Market, enhancing its visibility in the public market.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.